163 related articles for article (PubMed ID: 30878696)
1. Clinical characteristics of patients with paraneoplastic myelopathy.
Liu Z; Jiao L; Qiu Z; Da Y; Tang Y; Lin Y; Li D; Huang J; Kang X; Dong H
J Neuroimmunol; 2019 May; 330():136-142. PubMed ID: 30878696
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic/autoimmune myelopathies.
Montalvo M; Flanagan EP
Handb Clin Neurol; 2024; 200():193-201. PubMed ID: 38494277
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic necrotizing myelopathy in a patient with advanced esophageal cancer: An autopsied case report.
Urai Y; Matsumoto K; Shimamura M; Ikeda K; Tsukaguchi M; Deguchi K; Touge T; Ueno M; Sakamoto H; Kuriyama S; Kinekawa F; Kurokohchi K; Uchida N; Masaki T
J Neurol Sci; 2009 May; 280(1-2):113-7. PubMed ID: 19272613
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
5. A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody.
Mueller S; Dubal DB; Josephson SA
Nat Clin Pract Neurol; 2008 May; 4(5):284-8. PubMed ID: 18317500
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments.
Shah S; Vazquez Do Campo R; Kumar N; McKeon A; Flanagan EP; Klein C; Pittock SJ; Dubey D
Neurology; 2021 Jan; 96(4):e632-e639. PubMed ID: 33208548
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron disease of paraneoplastic origin: a rare but treatable condition.
Mélé N; Berzero G; Maisonobe T; Salachas F; Nicolas G; Weiss N; Beaudonnet G; Ducray F; Psimaras D; Lenglet T
J Neurol; 2018 Jul; 265(7):1590-1599. PubMed ID: 29725842
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic myelopathy.
Flanagan EP; Keegan BM
Neurol Clin; 2013 Feb; 31(1):307-18. PubMed ID: 23186906
[TBL] [Abstract][Full Text] [Related]
9. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic sensorimotor neuropathy and ventral cauda equina nerve root enhancement as initial presentation of small cell lung carcinoma: a case study.
Alsaeed M; Lim CAR; Plecash A; Chen T
BMC Neurol; 2021 Sep; 21(1):374. PubMed ID: 34579672
[TBL] [Abstract][Full Text] [Related]
11. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
13. [A case of paraneoplastic myelopathy associated with anti-CV2/CRMP5 antibodies with small-cell lung cancer].
Sato C; Kano T; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2020 Aug; 60(8):560-564. PubMed ID: 32641628
[TBL] [Abstract][Full Text] [Related]
14. Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.
Vogrig A; Joubert B; Maureille A; Thomas L; Bernard E; Streichenberger N; Cotton F; Ducray F; Honnorat J
J Neurol; 2019 Feb; 266(2):398-410. PubMed ID: 30498914
[TBL] [Abstract][Full Text] [Related]
15. Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.
Berzero G; Karantoni E; Dehais C; Ducray F; Thomas L; Picard G; Rogemond V; Candelier G; Camdessanché JP; Antoine JC; De Seze J; Liou-Schischmanoff A; Honnorat J; Delattre JY; Psimaras D
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):789-792. PubMed ID: 29084869
[No Abstract] [Full Text] [Related]
16. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
[TBL] [Abstract][Full Text] [Related]
17. Rapidly-progressive catatonia responsive to zolpidem in a patient with ovarian teratoma-associated paraneoplastic encephalitis.
Amorim E; McDade EM
J Clin Neurosci; 2016 Aug; 30():136-138. PubMed ID: 26964475
[TBL] [Abstract][Full Text] [Related]
18. Clinical and MRI phenotypes of sarcoidosis-associated myelopathy.
Murphy OC; Salazar-Camelo A; Jimenez JA; Barreras P; Reyes MI; Garcia MA; Moller DR; Chen ES; Pardo CA
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32269072
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune and paraneoplastic neurological disorders: A review of relevant neuroimaging findings.
Akkus S; Elkhooly M; Amatya S; Shrestha K; Sharma K; Kagzi Y; Khan E; Gupta R; Piquet AL; Jaiswal S; Wen S; Tapia M; Samant R; Sista SR; Sriwastava S
J Neurol Sci; 2023 Nov; 454():120830. PubMed ID: 37856996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
